{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:36:46Z","timestamp":1791175006862,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.addr.2005.01.028","type":"journal-article","created":{"date-parts":[[2005,4,22]],"date-time":"2005-04-22T13:32:26Z","timestamp":1114176746000},"page":"1266-1292","source":"Crossref","is-referenced-by-count":85,"title":["Molecular basis for improved anthrax vaccines"],"prefix":"10.1016","volume":"57","author":[{"given":"Robert N.","family":"Brey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2005.01.028_bib1","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1001\/jama.286.20.2554","article-title":"Death due to bioterrorism-related inhalational anthrax: report of 2 patients","volume":"286","author":"Borio","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2005.01.028_bib2","first-page":"941","article-title":"Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.addr.2005.01.028_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/jama.278.5.418","article-title":"Iraq's biological weapons. The past as future?","volume":"278","author":"Zilinskas","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2005.01.028_bib4","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management, Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2005.01.028_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jama.278.5.428","article-title":"Biological terrorism. Preparing to meet the threat","volume":"278","author":"Simon","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2005.01.028_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2005.01.028_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib8","series-title":"Bacterial Toxins and Virulence Factors in Disease","first-page":"543","article-title":"Anthrax toxins","volume":"vol. 8","author":"Leppla","year":"1995"},{"key":"10.1016\/j.addr.2005.01.028_bib9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2005.01.028_bib10","series-title":"The Anthrax Vaccine. Is it Safe? Does it work?","article-title":"Committee to assess the safety and efficacy of the anthrax vaccine","year":"2002"},{"key":"10.1016\/j.addr.2005.01.028_bib11","first-page":"70","article-title":"Summary of notifiable diseases, 1945\u20131994","volume":"43","author":"Centers for Disease Control and Prevention","year":"1994","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.addr.2005.01.028_bib12","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1378\/chest.116.5.1369","article-title":"Inhalational anthrax: epidemiology, diagnosis, and management","volume":"116","author":"Shafazand","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.addr.2005.01.028_bib13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.1980.tb18910.x","article-title":"Inhalation anthrax","volume":"353","author":"Brachman","year":"1980","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.addr.2005.01.028_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib15","first-page":"691","article-title":"Pathology of experimental inhalation anthrax in the rhesus monkey","volume":"73","author":"Fritz","year":"1995","journal-title":"Lab. Invest."},{"key":"10.1016\/j.addr.2005.01.028_bib16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.addr.2005.01.028_bib17","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalation anthrax","volume":"167","author":"Friedlander","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0264-410X(98)80112-6","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume":"16","author":"Ivins","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"Henderson","year":"1956","journal-title":"J. Hyg. (Lond.)"},{"key":"10.1016\/j.addr.2005.01.028_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(02)07792-9","article-title":"Anthrax inhalation and lethal human infection","volume":"359","author":"Peters","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2005.01.028_bib21","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.LAB.0000080599.43791.01","article-title":"Pathology of inhalation anthrax in cynomolgus monkeys (Macaca fascicularis)","volume":"83","author":"Vasconcelos","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.addr.2005.01.028_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/115.5.481","article-title":"Role of the lymphatics in the pathogenesis of anthrax","volume":"115","author":"Lincoln","year":"1965","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0076-6879(88)65019-1","article-title":"Production and purification of anthrax toxin","volume":"165","author":"Leppla","year":"1988","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2005.01.028_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/jb.171.2.722-730.1989","article-title":"Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis","volume":"171","author":"Makino","year":"1989","journal-title":"J. Bacteriol."},{"issue":"Pt. 2","key":"10.1016\/j.addr.2005.01.028_bib25","first-page":"557","article-title":"Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids","volume":"132","author":"Uchida","year":"1986","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/IAI.49.2.291-297.1985","article-title":"Demonstration of a capsule plasmid in Bacillus anthracis","volume":"49","author":"Green","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/IAI.51.3.795-800.1986","article-title":"Differences in susceptibility of inbred mice to Bacillus anthracis","volume":"51","author":"Welkos","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1006\/mpat.1993.1037","article-title":"Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence","volume":"14","author":"Welkos","year":"1993","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.addr.2005.01.028_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0882-4010(91)90053-D","article-title":"Plasmid-associated virulence factors of non-toxigenic (pX01\u2212) Bacillus anthracis","volume":"10","author":"Welkos","year":"1991","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.addr.2005.01.028_bib30","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/IAI.59.10.3472-3477.1991","article-title":"Contribution of individual toxin components to virulence of Bacillus anthracis","volume":"59","author":"Pezard","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.1988.39.575","article-title":"Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand","volume":"39","author":"Sirisanthana","year":"1988","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.addr.2005.01.028_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-1119(86)90044-2","article-title":"Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis","volume":"44","author":"Robertson","year":"1986","journal-title":"Gene"},{"key":"10.1016\/j.addr.2005.01.028_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(83)90402-6","article-title":"Cloning of the protective antigen gene of Bacillus anthracis","volume":"34","author":"Vodkin","year":"1983","journal-title":"Cell"},{"key":"10.1016\/j.addr.2005.01.028_bib34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-1119(88)90342-3","article-title":"Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli","volume":"64","author":"Mock","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.addr.2005.01.028_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-1119(88)90439-8","article-title":"Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis","volume":"69","author":"Welkos","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.addr.2005.01.028_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-1119(89)90335-1","article-title":"Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis","volume":"81","author":"Bragg","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.addr.2005.01.028_bib37","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib38","doi-asserted-by":"crossref","first-page":"15737","DOI":"10.1021\/bi981436i","article-title":"Characterization of membrane translocation by anthrax protective antigen","volume":"37","author":"Wesche","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/n35101998","article-title":"Crystal structure of the anthrax lethal factor","volume":"414","author":"Pannifer","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2672.1999.00888.x","article-title":"Crystallographic studies of the anthrax lethal toxin","volume":"87","author":"Liddington","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nature02763","article-title":"Crystal structure of a complex between anthrax toxin and its host cell receptor","volume":"430","author":"Santelli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1099\/00221287-26-1-49","article-title":"Purification of factor I and recognition of a third factor of the anthrax toxin","volume":"26","author":"Stanley","year":"1961","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/MMBR.68.3.373-402.2004","article-title":"Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins","volume":"68","author":"Barth","year":"2004","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.addr.2005.01.028_bib44","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1099\/00221287-139-10-2459","article-title":"Construction of Bacillus anthracis mutant strains producing a single toxin component","volume":"139","author":"Pezard","year":"1993","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/35102660","article-title":"Tackling anthrax","volume":"414","author":"Friedlander","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib46","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.89.21.10277","article-title":"Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin","volume":"89","author":"Klimpel","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib47","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/IAI.72.1.602-605.2004","article-title":"Protection against anthrax toxemia by hexa-d-arginine in vitro and in vivo","volume":"72","author":"Sarac","year":"2004","journal-title":"Infect. Immun."},{"issue":"Pt. 3","key":"10.1016\/j.addr.2005.01.028_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1099\/00221287-138-3-543","article-title":"Serum protease cleavage of Bacillus anthracis protective antigen","volume":"138","author":"Ezzell","year":"1992","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2958.1993.tb00936.x","article-title":"pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen","volume":"10","author":"Milne","year":"1993","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib50","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/bi000310u","article-title":"A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen","volume":"39","author":"Elliott","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib51","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/IAI.67.4.1853-1859.1999","article-title":"Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells","volume":"67","author":"Singh","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1083\/jcb.200211018","article-title":"Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process","volume":"160","author":"Abrami","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2005.01.028_bib53","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib54","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1128\/IAI.56.5.1066-1069.1988","article-title":"Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin","volume":"56","author":"Gordon","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1462-5822.2000.00052.x","article-title":"Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization","volume":"2","author":"Beauregard","year":"2000","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib56","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1073\/pnas.0431098100","article-title":"Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor","volume":"100","author":"Scobie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib57","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M210321200","article-title":"Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/n35101999","article-title":"Identification of the cellular receptor for anthrax toxin","volume":"414","author":"Bradley","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0006-291X(05)81097-6","article-title":"Location of receptor-binding region of protective antigen from Bacillus anthracis","volume":"180","author":"Little","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2005.01.028_bib60","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0300-483X(94)90153-8","article-title":"The channel formed in planar lipid bilayers by the protective antigen component of anthrax toxin","volume":"87","author":"Finkelstein","year":"1994","journal-title":"Toxicology"},{"key":"10.1016\/j.addr.2005.01.028_bib61","first-page":"188","article-title":"Channels formed in phospholipid bilayer membranes by diphtheria, tetanus, botulinum and anthrax toxin","volume":"84","author":"Finkelstein","year":"1990","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.addr.2005.01.028_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1574-6968.1994.tb07306.x","article-title":"Zinc content of the Bacillus anthracis lethal factor","volume":"124","author":"Kochi","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.addr.2005.01.028_bib63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1462-5822.2000.00057.x","article-title":"Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes","volume":"2","author":"Guidi-Rontani","year":"2000","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib64","doi-asserted-by":"crossref","first-page":"14939","DOI":"10.1021\/bi961518b","article-title":"Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a Fourier-transform infrared spectroscopy approach","volume":"35","author":"Wang","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib65","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1126\/science.109563","article-title":"Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax","volume":"292","author":"Sellman","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.addr.2005.01.028_bib66","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1006\/bbrc.2001.4320","article-title":"Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity","volume":"281","author":"Batra","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2005.01.028_bib67","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/IAI.67.2.964-967.1999","article-title":"Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen","volume":"67","author":"Brossier","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib68","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib69","doi-asserted-by":"crossref","first-page":"15493","DOI":"10.1016\/S0021-9258(18)98643-6","article-title":"The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity","volume":"266","author":"Singh","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib70","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.addr.2005.01.028_bib71","doi-asserted-by":"crossref","first-page":"30936","DOI":"10.1074\/jbc.M301154200","article-title":"Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody","volume":"278","author":"Rosovitz","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib72","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1016\/S0021-9258(19)62010-7","article-title":"The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor","volume":"269","author":"Singh","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib73","doi-asserted-by":"crossref","first-page":"19103","DOI":"10.1016\/S0021-9258(19)47273-6","article-title":"A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo","volume":"264","author":"Singh","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib74","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/IAI.68.4.1781-1786.2000","article-title":"Role of toxin functional domains in anthrax pathogenesis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib75","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib76","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1006\/bbrc.1994.1281","article-title":"Structure\u2013function analysis of Bacillus anthracis edema factor by using monoclonal antibodies","volume":"199","author":"Little","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2005.01.028_bib77","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1021\/bi00472a024","article-title":"Characterization of ATP and calmodulin-binding properties of a truncated form of Bacillus anthracis adenylate cyclase","volume":"29","author":"Labruyere","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib78","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0378-1119(88)90045-5","article-title":"Structural homology between virulence-associated bacterial adenylate cyclases","volume":"71","author":"Escuyer","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.addr.2005.01.028_bib79","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1016\/S0021-9258(19)39173-2","article-title":"A-type ATP binding consensus sequences are critical for the catalytic activity of the calmodulin-sensitive adenylyl cyclase from Bacillus anthracis","volume":"265","author":"Xia","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib80","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1021\/bi00224a008","article-title":"Structural and ligand-binding properties of a truncated form of Bacillus anthracis adenylate cyclase and of a catalytically inactive variant in which glutamine substitutes for lysine-346","volume":"30","author":"Labruyere","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib81","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1021\/bi00175a032","article-title":"The effects of pH on the interaction of anthrax toxin lethal and edema factors with phospholipid vesicles","volume":"33","author":"Kochi","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib82","doi-asserted-by":"crossref","first-page":"14906","DOI":"10.1021\/bi971661k","article-title":"Structure and interaction of PA63 and EF (edema toxin) of Bacillus anthracis with lipid membrane","volume":"36","author":"Wang","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.addr.2005.01.028_bib83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/IAI.47.1.306-310.1985","article-title":"Effects of anthrax toxin components on human neutrophils","volume":"47","author":"O'Brien","year":"1985","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib84","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1073\/pnas.90.21.10198","article-title":"On the role of macrophages in anthrax","volume":"90","author":"Hanna","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib85","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1462-5822.2000.00067.x","article-title":"Early Bacillus anthracis\u2013macrophage interactions: intracellular survival and escape","volume":"2","author":"Dixon","year":"2000","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib86","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s000180050399","article-title":"Anthrax toxins","volume":"55","author":"Duesbery","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2005.01.028_bib87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2672.1999.00893.x","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKS and induces tyrosine\/threonine phosphorylation of MAPKS in cultured macrophages","volume":"87","author":"Vitale","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/bbrc.2000.4099","article-title":"Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis","volume":"280","author":"Gupta","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2005.01.028_bib89","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1016\/S0021-9258(18)53698-X","article-title":"Residues 1\u2013254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides","volume":"268","author":"Arora","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib90","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1073\/pnas.0405754101","article-title":"Evidence that translocation of anthrax toxin's lethal factor is initiated by entry of its N terminus into the protective antigen channel","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib91","doi-asserted-by":"crossref","first-page":"20124","DOI":"10.1016\/S0021-9258(18)54899-7","article-title":"Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis","volume":"266","author":"Quinn","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2005.01.028_bib92","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.addr.2005.01.028_bib93","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(99)01502-1","article-title":"Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS\/IFNgamma-induced release of NO and TNFalpha","volume":"462","author":"Pellizzari","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.addr.2005.01.028_bib94","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.addr.2005.01.028_bib95","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1073\/pnas.061031898","article-title":"Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways","volume":"98","author":"Duesbery","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2958.1994.tb00500.x","article-title":"Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity","volume":"13","author":"Klimpel","year":"1994","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib97","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/IAI.72.1.430-439.2004","article-title":"Anthrax lethal toxin induces human endothelial cell apoptosis","volume":"72","author":"Kirby","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib98","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1099\/00221287-29-3-517","article-title":"Purification of the third factor of anthrax toxin","volume":"29","author":"Smith","year":"1962","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib99","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/173869a0","article-title":"Observations on experimental anthrax; demonstration of a specific lethal factor produced in vivo by Bacillus anthracis","volume":"173","author":"Smith","year":"1954","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s002849900104","article-title":"Cytotoxic effects of anthrax lethal toxin on macrophage-like cell line J774A.1","volume":"33","author":"Lin","year":"1996","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib101","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/IAI.69.2.1175-1177.2001","article-title":"Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin","volume":"69","author":"Erwin","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib102","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.1073163","article-title":"Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition","volume":"297","author":"Park","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.addr.2005.01.028_bib103","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1365-2958.1998.00953.x","article-title":"Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11","volume":"29","author":"Roberts","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib104","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0960-9822(01)00476-6","article-title":"Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor","volume":"11","author":"Watters","year":"2001","journal-title":"Curr. Biol."},{"key":"10.1016\/j.addr.2005.01.028_bib105","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0002-9440(10)63532-8","article-title":"Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci","volume":"163","author":"McAllister","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2005.01.028_bib106","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1128\/IAI.67.6.3055-3060.1999","article-title":"Proteasome activity is required for anthrax lethal toxin to kill macrophages","volume":"67","author":"Tang","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib107","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature01794","article-title":"Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin","volume":"424","author":"Agrawal","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib108","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1172\/JCI17991","article-title":"Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice","volume":"112","author":"Moayeri","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2005.01.028_bib109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/bbrc.2002.6626","article-title":"TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection","volume":"292","author":"Kalns","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2005.01.028_bib110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2958.1999.01137.x","article-title":"Germination of Bacillus anthracis spores within alveolar macrophages","volume":"31","author":"Guidi-Rontani","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib111","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/IAI.72.5.3069-3072.2004","article-title":"Macrophages release tumor necrosis factor alpha and interleukin-12 in response to intracellular Bacillus anthracis spores","volume":"72","author":"Pickering","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib112","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1128\/IAI.72.11.6382-6389.2004","article-title":"Cytokine response to infection with Bacillus anthracis spores","volume":"72","author":"Pickering","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib113","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","article-title":"Development of novel vaccines against anthrax in man","volume":"44","author":"Stepanov","year":"1996","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.addr.2005.01.028_bib114","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1086\/341299","article-title":"Effect of the lower molecular capsule released from the cell surface of Bacillus anthracis on the pathogenesis of anthrax","volume":"186","author":"Makino","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib116","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1016\/S0264-410X(01)00197-9","article-title":"Passive transfer of protection against Bacillus anthracis infection in a murine model","volume":"19","author":"Beedham","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib117","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/IAI.65.12.5171-5175.1997","article-title":"Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs","volume":"65","author":"Little","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib118","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons","volume":"8","author":"Casadevall","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib119","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0882-4010(88)90015-0","article-title":"Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice","volume":"5","author":"Welkos","year":"1988","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.addr.2005.01.028_bib120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/IAI.70.2.544-550.2002","article-title":"Efficiency of protection of guinea pigs against infection with Bacillus anthracis spores by passive immunization","volume":"70","author":"Kobiler","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/milmed\/151.2.71","article-title":"Treatment of anthrax in man: history and current concepts","volume":"151","author":"Knudson","year":"1986","journal-title":"Mil. Med."},{"key":"10.1016\/j.addr.2005.01.028_bib122","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2005.01.028_bib123","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-8518-2-5","article-title":"Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed","volume":"2","author":"Sawada-Hirai","year":"2004","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"10.1016\/j.addr.2005.01.028_bib124","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1128\/IAI.72.6.3276-3283.2004","article-title":"Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages","volume":"72","author":"Mohamed","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib125","article-title":"Protection against inhalation anthrax-induced lethality by a human monoclonal antibody to protective antigen in rabbits and cynomolgus monkeys","author":"Beebe","year":"2003"},{"key":"10.1016\/j.addr.2005.01.028_bib126","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1128\/IAI.72.11.6313-6317.2004","article-title":"Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies","volume":"72","author":"Brossier","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib127","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1073\/pnas.0401351101","article-title":"mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia","volume":"101","author":"Kozel","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/IAI.52.2.356-363.1986","article-title":"Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity","volume":"52","author":"Turnbull","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib129","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib130","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.vaccine.2003.07.004","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume":"22","author":"Little","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib131","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib132","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/313812","article-title":"Immunization against potential biological warfare agents","volume":"30","author":"Cieslak","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib133","series-title":"Vaccines","first-page":"629","article-title":"Anthrax","author":"Brachman","year":"1999"},{"key":"10.1016\/j.addr.2005.01.028_bib134","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0264-410X(91)90237-Z","article-title":"Anthrax vaccines: past, present and future","volume":"9","author":"Turnbull","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(84)90003-3","article-title":"Anthrax: the disease in relation to vaccines","volume":"2","author":"Hambleton","year":"1984","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib136","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib137","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00001432-200004000-00004","article-title":"Current status of immunization against anthrax: old vaccines may be here to stay for a while","volume":"13","author":"Turnbull","year":"2000","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"RR-15","key":"10.1016\/j.addr.2005.01.028_bib138","first-page":"1","article-title":"Use of anthrax vaccine in the United States. Recommendation of the Advisory Committee on Immunization Practices","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.addr.2005.01.028_bib139","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.282.22.2104","article-title":"Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax","volume":"282","author":"Friedlander","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2005.01.028_bib140","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.addr.2005.01.028_bib141","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"Fellows","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib142","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs","volume":"12","author":"Ivins","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib143","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"Jama"},{"key":"10.1016\/j.addr.2005.01.028_bib144","first-page":"341","article-title":"Surveillance for adverse events associated with anthrax vaccination\u2014U.S. Department of Defense, 1998\u20132000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.addr.2005.01.028_bib145","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/S0264-410X(02)00092-0","article-title":"Monitoring anthrax vaccine safety in US military service members on active duty: surveillance of 1998 hospitalizations in temporal association with anthrax immunization","volume":"20","author":"Sato","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib146","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.287.12.1556","article-title":"Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women","volume":"287","author":"Wiesen","year":"2002","journal-title":"Jama"},{"key":"10.1016\/j.addr.2005.01.028_bib147","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib148","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0264-410X(00)00174-2","article-title":"Anthrax vaccine: increasing intervals between the first two doses enhances antibody response in humans","volume":"19","author":"Pittman","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib149","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1046\/j.1365-2672.1998.00405.x","article-title":"The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis","volume":"84","author":"Baillie","year":"1998","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1128\/AEM.68.1.227-234.2002","article-title":"Optimization of the cell wall microenvironment allows increased production of recombinant Bacillus anthracis protective antigen from B. subtilis","volume":"68","author":"Thwaite","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib151","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AEM.64.3.982-991.1998","article-title":"Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis","volume":"64","author":"Farchaus","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib152","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pep.2004.08.007","article-title":"Production purification of Bacillus anthracis protective antigen from Escherichia coli","volume":"38","author":"Laird","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.addr.2005.01.028_bib153","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1016\/j.vaccine.2004.01.069","article-title":"Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food\/feed crop","volume":"22","author":"Watson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib154","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1128\/IAI.52.2.509-512.1986","article-title":"Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig","volume":"52","author":"Little","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib155","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"Brossier","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib156","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","article-title":"Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax","volume":"68","author":"Cohen","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib157","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/IAI.63.4.1369-1372.1995","article-title":"Protective immunity induced by Bacillus anthracis toxin-deficient strains","volume":"63","author":"Pezard","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib158","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4899-1382-1_10","article-title":"Protective immunity induced by Bacillus anthracis toxin mutant strains","volume":"397","author":"Pezard","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.addr.2005.01.028_bib159","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1128\/IAI.58.2.303-308.1990","article-title":"Immunization against anthrax with aromatic compound-dependent (Aro\u2212) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume":"58","author":"Ivins","year":"1990","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib160","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1128\/IAI.52.2.454-458.1986","article-title":"Immunization studies with attenuated strains of Bacillus anthracis","volume":"52","author":"Ivins","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib161","first-page":"506","article-title":"Development of anthrax DNA vaccines","volume":"6","author":"Ferrari","year":"2004","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.addr.2005.01.028_bib162","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.vaccine.2003.09.043","article-title":"Genetic immunization against anthrax","volume":"22","author":"Galloway","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib163","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Price","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib164","doi-asserted-by":"crossref","first-page":"13601","DOI":"10.1073\/pnas.0405557101","article-title":"A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores","volume":"101","author":"Hermanson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib165","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib166","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib167","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib168","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly(gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib169","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-8244(03)00366-3","article-title":"Induction of opsonic antibodies to the gamma-d-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide\u2013carrier protein conjugate","volume":"40","author":"Wang","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nature01586","article-title":"The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria","volume":"423","author":"Read","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.addr.2005.01.028_bib171","doi-asserted-by":"crossref","first-page":"6817","DOI":"10.1128\/IAI.70.12.6817-6827.2002","article-title":"Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening","volume":"70","author":"Ariel","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib172","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1128\/IAI.71.8.4563-4579.2003","article-title":"Genome-based bioinformatic selection of chromosomal Bacillus anthracis putative vaccine candidates coupled with proteomic identification of surface-associated antigens","volume":"71","author":"Ariel","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib173","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.vaccine.2003.12.020","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume":"22","author":"Klinman","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib174","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.vaccine.2003.11.064","article-title":"Pluronic F127-based systemic vaccine delivery systems","volume":"22","author":"Coeshott","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib175","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2672.1999.00900.x","article-title":"Expression of the protective antigen of Bacillus anthracis by Lactobacillus casei: towards the development of an oral vaccine against anthrax","volume":"87","author":"Zegers","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib176","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1128\/IAI.59.6.1961-1965.1991","article-title":"Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals","volume":"59","author":"Iacono-Connors","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib177","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1128\/IAI.71.7.3831-3836.2003","article-title":"Salmonella enterica serovar typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge","volume":"71","author":"Garmory","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib178","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0264-410X(94)90148-1","article-title":"Bacillus anthracis protective antigen, expressed in Salmonella typhimurium SL 3261, affords protection against anthrax spore challenge","volume":"12","author":"Coulson","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib179","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/422694","article-title":"Induction of protective immunity against lethal anthrax challenge with a patch","volume":"190","author":"Kenney","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2005.01.028_bib180","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/S0264-410X(02)00207-4","article-title":"Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin","volume":"20","author":"Gaur","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib181","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1128\/IAI.70.4.2022-2028.2002","article-title":"Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib182","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.170.11.5636","article-title":"Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen","volume":"170","author":"Boyaka","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2005.01.028_bib183","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/IAI.72.2.1181-1183.2004","article-title":"Needle-free skin patch vaccination method for anthrax","volume":"72","author":"Matyas","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib184","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0264-410X(94)90223-2","article-title":"Human live anthrax vaccine in the former USSR","volume":"12","author":"Shlyakhov","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib185","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/IAI.60.2.662-668.1992","article-title":"Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants","volume":"60","author":"Ivins","year":"1992","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib186","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1128\/IAI.72.6.3471-3477.2004","article-title":"Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine","volume":"72","author":"Marcus","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib187","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib188","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1574-6968.1997.tb12786.x","article-title":"Anthrax lethal toxin-induced mitogenic response of human T-cells","volume":"157","author":"Guidi-Rontani","year":"1997","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.addr.2005.01.028_bib189","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijmm.2003.12.002","article-title":"Protection of mice against challenge with Bacillus anthracis STI spores after DNA vaccination","volume":"294","author":"Hahn","year":"2004","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.addr.2005.01.028_bib190","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib191","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/0264-410X(95)00139-R","article-title":"Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs","volume":"13","author":"Ivins","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib192","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0264-410X(99)00443-0","article-title":"CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans","volume":"18","author":"Davis","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2005.01.028_bib193","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smim.2003.10.009","article-title":"Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9","volume":"16","author":"Takeshita","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.addr.2005.01.028_bib194","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"key":"10.1016\/j.addr.2005.01.028_bib195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1042\/BA20000037","article-title":"Anthrax toxin-mediated delivery of cholera toxin-A subunit into the cytosol of mammalian cells","volume":"32","author":"Sharma","year":"2000","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.addr.2005.01.028_bib196","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1073\/pnas.93.16.8437","article-title":"Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen","volume":"93","author":"Blanke","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib197","doi-asserted-by":"crossref","first-page":"12531","DOI":"10.1073\/pnas.93.22.12531","article-title":"Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo","volume":"93","author":"Ballard","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib198","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1128\/IAI.67.7.3290-3296.1999","article-title":"Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity","volume":"67","author":"Doling","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib199","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1073\/pnas.97.14.8027","article-title":"Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity","volume":"97","author":"Lu","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib200","doi-asserted-by":"crossref","first-page":"12059","DOI":"10.1073\/pnas.94.22.12059","article-title":"Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein","volume":"94","author":"Goletz","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2005.01.028_bib201","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/IAI.68.10.5731-5734.2000","article-title":"Protective antigen-mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2005.01.028_bib202","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/IAI.54.2.537-542.1986","article-title":"Cloning and expression of the Bacillus anthracis protective antigen gene in Bacillus subtilis","volume":"54","author":"Ivins","year":"1986","journal-title":"Infect. Immun."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X0500044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X0500044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T15:42:15Z","timestamp":1625845335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X0500044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":202,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0169409X0500044X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2005.01.028","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}